M, F., H, N., CM, B., B, G., A, C., S, T., . . . AK, W. (2021). Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018. JAMA internal medicine, 181(12), 1596. https://doi.org/10.1001/jamainternmed.2021.5983
Chicago Style (17th ed.) CitationM, Fu, et al. "Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018." JAMA Internal Medicine 181, no. 12 (2021): 1596. https://doi.org/10.1001/jamainternmed.2021.5983.
MLA (9th ed.) CitationM, Fu, et al. "Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018." JAMA Internal Medicine, vol. 181, no. 12, 2021, p. 1596, https://doi.org/10.1001/jamainternmed.2021.5983.
Warning: These citations may not always be 100% accurate.